武汉大学主页平台管理系统 Tian Jianbo--Home--Paper Publications

Home > Scientific Research > Paper Publications

[1]. Can Chen#, Yimin Cai#, Wenlong Hu#, Kai Tan#, Zequn Lu#, Xuanyu Zhu#, ......, Jianbo Tian* & Xiaoping Miao* Single-cell eQTL mapping reveals cell subtype-specific genetic control and mechanism in malignant transformation of colorectal cancer. Cancer Discovery 2025 (IF:30.6, 中科院1区).
[2]. Yimin Cai#, Zequn Lu#, Can Chen#, Ying Zhu#, ...... ，Jianbo Tian* & Xiaoping Miao*. An atlas of genetic effects on cellular composition of the tumor microenvironment. Nat Immunol 2024 (IF:27.7，中科院1区).
[3]. Cai Yimin#, Lu Zequn#, Li Bin# ...... Miao Xiaoping*, Zhang Shaokai*, Wei Yongchang*, Tian Jianbo* Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers. Mil Med Res 2024.11(1):36 (IF:16.7, 中科院1区).
[4]. Tian Jianbo*，Zhang Ming#, Zhang Fuwei#, Gao Kai# ...... Jin Mingjuan*, Miao Xiaoping*, Chen Kun*. Developing an optimal stratification model for colorectal cancer screening and reducing racial disparities in multi-center population-based studies. Genome Medicine 2024,16(1):81（IF:10.4, 中科院1区）.
[5]. Ying Pingting#, Chen Can#, Lu Zequn #, ...... ,Tian Jianbo*, Miao Xiaoping*. Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk.. Nature communications 2023,14(1):5958（IF:16.6, 中科院1区）.
[6]. Ming Zhang#, Xiaoyang Wang#, Nan Yang#, Xu Zhu#, ...... , Shaokai Zhang*, Jianbo Tian*, Xiaoping Miao*. Prioritization of risk genes in colorectal cancer by integrative analysis of multi-omics data and gene networks. Science China Life Science (IF:9.1, 中科院1区).
[7]. Bin Li#, Yimin Cai#, Can Chen#, ......, Jianbo Tian*, Xiaoping Miao*. Genetic variants that impact alternative polyadenylation in cancer represent candidate causal risk loci. Cancer Research (IF:13.21，中科院1区).
[8]. Ming Zhang#, Can Chen#, Zequn Lu#, ... , Jianbo Tian*, Xiaoping Miao*. Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms. Gastroenterology 2023, S0016-5085(23)04839-4 (IF:29.4, 中科院1区).
[9]. Meng Jin#, Bo Liu#, Can Chen#, ......., Jianbo Tian*, Ke Hu* Genome-wide splicing QTL analysis identifies causal risk variants for non-small cell lung cancer. Cancer Res. 2023 (IF: 13.31, 中科院1区).
[10]. Wang Haoxue#, Cai Yimin#, Jin Meng#, Huang ChaoQun#, et al ......Yang Xiaojun*, Chang Jiang*, Li Ni*, Tian Jianbo* Identification of specific susceptibility loci for the early-onset colorectal cancer. Genome Med. 2023,15(1):13 (IF:15.266, 中科院1区).
[11]. Chen Can#, Cai Yimin#, Liu Yizhuo#, et al ....... Miao Xiaoping, Yang Xiaojun*, Zhu Ying*, Tian Jianbo* Pan-cancer analysis of microbiome quantitative trait loci. Cancer Res. 2022, 82(19):3449-3456 (IF: 12.701, 中科院1区).
[12]. Tian Jianbo#*, Chen Can#, Rao Meilin#, et al ...... Yang Xiaojun*, Miao Xiaoping* Aberrant RNA splicing is a primary link between genetic variation and pancreatic cancer risk. Cancer Res. 2022, 82(11):2084-2096 (IF: 12.701,中科院1区).
[13]. Tian Jianbo#, Yuan Xianglin#, Xiao Jun#, Zhong Qiang#, Yang Chunguang#, Liu Bo#, Cai Yimin#, Lu Zequn# et al …… Miao Xiaoping, Wang Zhihua* Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. The Lancet Oncology, 2020, 21(7): 893-903.
[14]. Tian Jianbo#, Zhu Ying#, et al …… Chang Jiang*, Miao Xiaoping*. N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression. Gut, 2020, 69(12): 2180-2192.
[15]. Tian Jianbo#, Chang Jiang#, Gong Jing#, et al…… Miao Xiaoping*. Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction. American journal of human genetics, 2019, 105(1): 29-47. (IF: 11.025, 中科院1区).
[16]. Tian Jianbo#, Lou Jiao# et al…… Miao Xiaoping*. Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both FADS2 and AP002754.2. Cancer research, 2020, 80(9): 1804-1818. (IF: 12.701, 中科院1区).
[17]. Tian Jianbo#, Cai Yimin#, et al…… Miao Xiaoping*. CancerImmunityQTL: a database to systematically evaluate the impact of genetic variants on immune infiltration in human cancer. Nucleic acids research, 2021, 49(D1): D1065-D1073. (IF:16.971, 中科院1区).
[18]. Tian Jianbo#, Wang Zhihua#, et al…… Gong Jing*, Han Leng*, Miao Xiaoping*. CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer. Nucleic acids research, 2019, 47(D1): D909-D916. (IF:16.971, 中科院1区).
[19]. Chang Jiang#, Zhong Rong#, Tian Jianbo#, Li Jiaoyuan#, et al…… Wu Chen*, Miao Xiaoping*, Lin Dongxin. Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma. Nature genetics, 2018, 50(3): 338-343. (IF: 38.330, 中科院1区).
[20]. Gong Jing#, Tian Jianbo#, et al …… Miao Xiaoping*. A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267. Annals of oncology, 2018, 29(3): 632-639. (IF: 32.976, 中科院1区).
[21]. Chang Jiang#, Tian Jianbo#, Zhu Ying#, Zhong Rong#, et al…… Wu Chen*, Lin Dongxin*, Miao Xiaoping*. Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations. Nat Commun, 2018, 9(1): 3688. (IF: 14.919, 中科院1区).
[22]. Chang Jiang#, Tian Jianbo#, Yang Yang#, Zhong Rong#, et al…… Miao Xiaoping. A Rare Missense Variant in TCF7L2 Associates with Colorectal Cancer Risk by Interacting with a GWAS-Identified Regulatory Variant in the MYC Enhancer. Cancer research, 2018, 78(17): 5164-5172. (IF: 12.701, 中科院1区).
[23]. Tian Jianbo#, Ying Pingting#, et al…… Chang Jiang*, Miao Xiaoping*. ANKLE1 N6-Methyladenosine-related variant is associated with colorectal cancer risk by maintaining the genomic stability. International journal of cancer, 2020, 146(12): 3281-3293. (IF: 7.396, 中科院1区).
[24]. Zhong Rong#, Tian Jianbo#, et al…… Miao Xiaoping. LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk. Oncogene, 2020, 39(9): 1944-1956. (IF: 9.867, 中科院1区).
[25]. Wang Haoxue, et al…… Tian Jianbo*, Miao Xiaoping*. Colorectal cancer risk variant rs7017386 modulates two oncogenic lncRNAs expression via ATF1-mediated long-range chromatin loop. Cancer Lett, 2021, (IF: 8.671, 中科院1区).
[26]. Ying Pingting, et al…… Tian Jianbo*, Chang Jiang*. Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population. Arch Toxicol, 2021, 95(3): 1117-1128. (IF: 5.153, 中科院1区).
[27]. Jianbo Tian*, Ming Zhang*, Meng Jin* et al ...... Ke Hu*, Xiaoping Miao*, Huilan Zhang*. Repurposed Tocilizumab in Patients with Severe COVID-19. J Immunol 2021; 206(3):599-606. (IF: 5.424).
[28]. Zhong rong#, He heng#, et al ...... Tian Jianbo. Genome-wide gene-bisphenol A, F and triclosan interaction analyses on urinary oxidative s tress markers. Science of the Total Environment, 2022, 807(Pt1): 0-150753.(IF: 7.963).
[29]. Ying Zhu*, Jianbo Tian* et al ...... Xiaoping Miao. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis. Eur J Cancer 2021;6:31006. (IF: 9.162, 中科院1 区).
[30]. 田剑波 ...... 李江、李霓、赫捷. 全球结直肠癌筛查指南及共识质量评价. 中华流行病学杂志 2021 (中文核心).
[31]. 田剑波, 缪小平, 林东昕. 中国人群常见恶性肿瘤遗传风险预测模型研究进展. 生物产业技术 2016;0 (中文核心).

total31 1/1

firstpreviousnextlast

Recommended Ph.D.Supervisor

Recommended MA Supervisor

Personal Information

Other Contact Information

[1]. Can Chen#, Yimin Cai#, Wenlong Hu#, Kai Tan#, Zequn Lu#, Xuanyu Zhu#, ......, Jianbo Tian* & Xiaoping Miao* Single-cell eQTL mapping reveals cell subtype-specific genetic control and mechanism in malignant transformation of colorectal cancer. Cancer Discovery 2025 (IF:30.6, 中科院1区).

[2]. Yimin Cai#, Zequn Lu#, Can Chen#, Ying Zhu#, ...... ，Jianbo Tian* & Xiaoping Miao. An atlas of genetic effects on cellular composition of the tumor microenvironment.* Nat Immunol 2024 (IF:27.7，中科院1区).

[3]. Cai Yimin#, Lu Zequn#, Li Bin# ...... Miao Xiaoping, Zhang Shaokai, Wei Yongchang, Tian Jianbo Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers. Mil Med Res 2024.11(1):36 (IF:16.7, 中科院1区).

[5]. Ying Pingting#, Chen Can#, Lu Zequn #, ...... ,Tian Jianbo, Miao Xiaoping. Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk.. Nature communications 2023,14(1):5958（IF:16.6, 中科院1区）.

[6]. Ming Zhang#, Xiaoyang Wang#, Nan Yang#, Xu Zhu#, ...... , Shaokai Zhang, Jianbo Tian, Xiaoping Miao. Prioritization of risk genes in colorectal cancer by integrative analysis of multi-omics data and gene networks.* Science China Life Science (IF:9.1, 中科院1区).

[7]. Bin Li#, Yimin Cai#, Can Chen#, ......, Jianbo Tian, Xiaoping Miao. Genetic variants that impact alternative polyadenylation in cancer represent candidate causal risk loci. Cancer Research (IF:13.21，中科院1区).

[8]. Ming Zhang#, Can Chen#, Zequn Lu#, ... , Jianbo Tian, Xiaoping Miao. Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms. Gastroenterology 2023, S0016-5085(23)04839-4 (IF:29.4, 中科院1区).

[9]. Meng Jin#, Bo Liu#, Can Chen#, ......., Jianbo Tian, Ke Hu Genome-wide splicing QTL analysis identifies causal risk variants for non-small cell lung cancer. Cancer Res. 2023 (IF: 13.31, 中科院1区).

[10]. Wang Haoxue#, Cai Yimin#, Jin Meng#, Huang ChaoQun#, et al ......Yang Xiaojun, Chang Jiang, Li Ni, Tian Jianbo Identification of specific susceptibility loci for the early-onset colorectal cancer. Genome Med. 2023,15(1):13 (IF:15.266, 中科院1区).

[11]. Chen Can#, Cai Yimin#, Liu Yizhuo#, et al ....... Miao Xiaoping, Yang Xiaojun, Zhu Ying, Tian Jianbo* Pan-cancer analysis of microbiome quantitative trait loci. Cancer Res. 2022, 82(19):3449-3456 (IF: 12.701, 中科院1区).

[12]. Tian Jianbo#, Chen Can#, Rao Meilin#, et al ...... Yang Xiaojun, Miao Xiaoping* Aberrant RNA splicing is a primary link between genetic variation and pancreatic cancer risk. Cancer Res. 2022, 82(11):2084-2096 (IF: 12.701,中科院1区).

[14]. Tian Jianbo#, Zhu Ying#, et al …… Chang Jiang, Miao Xiaoping. N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression. Gut, 2020, 69(12): 2180-2192.

[16]. Tian Jianbo#, Lou Jiao# et al…… Miao Xiaoping. Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both FADS2 and AP002754.2.* Cancer research, 2020, 80(9): 1804-1818. (IF: 12.701, 中科院1区).

[17]. Tian Jianbo#, Cai Yimin#, et al…… Miao Xiaoping. CancerImmunityQTL: a database to systematically evaluate the impact of genetic variants on immune infiltration in human cancer.* Nucleic acids research, 2021, 49(D1): D1065-D1073. (IF:16.971, 中科院1区).

[18]. Tian Jianbo#, Wang Zhihua#, et al…… Gong Jing, Han Leng, Miao Xiaoping. CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer.* Nucleic acids research, 2019, 47(D1): D909-D916. (IF:16.971, 中科院1区).

[20]. Gong Jing#, Tian Jianbo#, et al …… Miao Xiaoping. A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267.* Annals of oncology, 2018, 29(3): 632-639. (IF: 32.976, 中科院1区).

[21]. Chang Jiang#, Tian Jianbo#, Zhu Ying#, Zhong Rong#, et al…… Wu Chen, Lin Dongxin, Miao Xiaoping. Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations.* Nat Commun, 2018, 9(1): 3688. (IF: 14.919, 中科院1区).

[23]. Tian Jianbo#, Ying Pingting#, et al…… Chang Jiang, Miao Xiaoping. ANKLE1 N6-Methyladenosine-related variant is associated with colorectal cancer risk by maintaining the genomic stability. International journal of cancer, 2020, 146(12): 3281-3293. (IF: 7.396, 中科院1区).

[24]. Zhong Rong#, Tian Jianbo#, et al…… Miao Xiaoping. LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk. Oncogene, 2020, 39(9): 1944-1956. (IF: 9.867, 中科院1区).

[25]. Wang Haoxue, et al…… Tian Jianbo, Miao Xiaoping. Colorectal cancer risk variant rs7017386 modulates two oncogenic lncRNAs expression via ATF1-mediated long-range chromatin loop. Cancer Lett, 2021, (IF: 8.671, 中科院1区).

[26]. Ying Pingting, et al…… Tian Jianbo, Chang Jiang. Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population. Arch Toxicol, 2021, 95(3): 1117-1128. (IF: 5.153, 中科院1区).

[27]. Jianbo Tian, Ming Zhang, Meng Jin* et al ...... Ke Hu, Xiaoping Miao, Huilan Zhang. Repurposed Tocilizumab in Patients with Severe COVID-19.* J Immunol 2021; 206(3):599-606. (IF: 5.424).

[28]. Zhong rong#, He heng#, et al ...... Tian Jianbo. Genome-wide gene-bisphenol A, F and triclosan interaction analyses on urinary oxidative s tress markers. Science of the Total Environment, 2022, 807(Pt1): 0-150753.(IF: 7.963).

[29]. Ying Zhu, Jianbo Tian et al ...... Xiaoping Miao. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis. Eur J Cancer 2021;6:31006. (IF: 9.162, 中科院1 区).

[30]. 田剑波 ...... 李江、李霓、赫捷. 全球结直肠癌筛查指南及共识质量评价. 中华流行病学杂志 2021 (中文核心).

[31]. 田剑波, 缪小平, 林东昕. 中国人群常见恶性肿瘤遗传风险预测模型研究进展. 生物产业技术 2016;0 (中文核心).

Recommended Ph.D.Supervisor

Recommended MA Supervisor

Personal Information

Other Contact Information

[1]. Can Chen#, Yimin Cai#, Wenlong Hu#, Kai Tan#, Zequn Lu#, Xuanyu Zhu#, ......, Jianbo Tian* & Xiaoping Miao* Single-cell eQTL mapping reveals cell subtype-specific genetic control and mechanism in malignant transformation of colorectal cancer. Cancer Discovery 2025 (IF:30.6, 中科院1区).

[2]. Yimin Cai#, Zequn Lu#, Can Chen#, Ying Zhu#, ...... ，Jianbo Tian* & Xiaoping Miao*. An atlas of genetic effects on cellular composition of the tumor microenvironment. Nat Immunol 2024 (IF:27.7，中科院1区).

[3]. Cai Yimin#, Lu Zequn#, Li Bin# ...... Miao Xiaoping*, Zhang Shaokai*, Wei Yongchang*, Tian Jianbo* Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers. Mil Med Res 2024.11(1):36 (IF:16.7, 中科院1区).

[5]. Ying Pingting#, Chen Can#, Lu Zequn #, ...... ,Tian Jianbo*, Miao Xiaoping*. Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk.. Nature communications 2023,14(1):5958（IF:16.6, 中科院1区）.

[6]. Ming Zhang#, Xiaoyang Wang#, Nan Yang#, Xu Zhu#, ...... , Shaokai Zhang*, Jianbo Tian*, Xiaoping Miao*. Prioritization of risk genes in colorectal cancer by integrative analysis of multi-omics data and gene networks. Science China Life Science (IF:9.1, 中科院1区).

[7]. Bin Li#, Yimin Cai#, Can Chen#, ......, Jianbo Tian*, Xiaoping Miao*. Genetic variants that impact alternative polyadenylation in cancer represent candidate causal risk loci. Cancer Research (IF:13.21，中科院1区).

[8]. Ming Zhang#, Can Chen#, Zequn Lu#, ... , Jianbo Tian*, Xiaoping Miao*. Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms. Gastroenterology 2023, S0016-5085(23)04839-4 (IF:29.4, 中科院1区).

[9]. Meng Jin#, Bo Liu#, Can Chen#, ......., Jianbo Tian*, Ke Hu* Genome-wide splicing QTL analysis identifies causal risk variants for non-small cell lung cancer. Cancer Res. 2023 (IF: 13.31, 中科院1区).

[10]. Wang Haoxue#, Cai Yimin#, Jin Meng#, Huang ChaoQun#, et al ......Yang Xiaojun*, Chang Jiang*, Li Ni*, Tian Jianbo* Identification of specific susceptibility loci for the early-onset colorectal cancer. Genome Med. 2023,15(1):13 (IF:15.266, 中科院1区).

[11]. Chen Can#, Cai Yimin#, Liu Yizhuo#, et al ....... Miao Xiaoping, Yang Xiaojun*, Zhu Ying*, Tian Jianbo* Pan-cancer analysis of microbiome quantitative trait loci. Cancer Res. 2022, 82(19):3449-3456 (IF: 12.701, 中科院1区).

[12]. Tian Jianbo#*, Chen Can#, Rao Meilin#, et al ...... Yang Xiaojun*, Miao Xiaoping* Aberrant RNA splicing is a primary link between genetic variation and pancreatic cancer risk. Cancer Res. 2022, 82(11):2084-2096 (IF: 12.701,中科院1区).

[14]. Tian Jianbo#, Zhu Ying#, et al …… Chang Jiang*, Miao Xiaoping*. N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression. Gut, 2020, 69(12): 2180-2192.

[16]. Tian Jianbo#, Lou Jiao# et al…… Miao Xiaoping*. Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both FADS2 and AP002754.2. Cancer research, 2020, 80(9): 1804-1818. (IF: 12.701, 中科院1区).

[17]. Tian Jianbo#, Cai Yimin#, et al…… Miao Xiaoping*. CancerImmunityQTL: a database to systematically evaluate the impact of genetic variants on immune infiltration in human cancer. Nucleic acids research, 2021, 49(D1): D1065-D1073. (IF:16.971, 中科院1区).

[18]. Tian Jianbo#, Wang Zhihua#, et al…… Gong Jing*, Han Leng*, Miao Xiaoping*. CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer. Nucleic acids research, 2019, 47(D1): D909-D916. (IF:16.971, 中科院1区).

[20]. Gong Jing#, Tian Jianbo#, et al …… Miao Xiaoping*. A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267. Annals of oncology, 2018, 29(3): 632-639. (IF: 32.976, 中科院1区).

[23]. Tian Jianbo#, Ying Pingting#, et al…… Chang Jiang*, Miao Xiaoping*. ANKLE1 N6-Methyladenosine-related variant is associated with colorectal cancer risk by maintaining the genomic stability. International journal of cancer, 2020, 146(12): 3281-3293. (IF: 7.396, 中科院1区).

[24]. Zhong Rong#, Tian Jianbo#, et al…… Miao Xiaoping. LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk. Oncogene, 2020, 39(9): 1944-1956. (IF: 9.867, 中科院1区).

[25]. Wang Haoxue, et al…… Tian Jianbo*, Miao Xiaoping*. Colorectal cancer risk variant rs7017386 modulates two oncogenic lncRNAs expression via ATF1-mediated long-range chromatin loop. Cancer Lett, 2021, (IF: 8.671, 中科院1区).

[26]. Ying Pingting, et al…… Tian Jianbo*, Chang Jiang*. Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population. Arch Toxicol, 2021, 95(3): 1117-1128. (IF: 5.153, 中科院1区).

[27]. Jianbo Tian*, Ming Zhang*, Meng Jin* et al ...... Ke Hu*, Xiaoping Miao*, Huilan Zhang*. Repurposed Tocilizumab in Patients with Severe COVID-19. J Immunol 2021; 206(3):599-606. (IF: 5.424).

[28]. Zhong rong#, He heng#, et al ...... Tian Jianbo. Genome-wide gene-bisphenol A, F and triclosan interaction analyses on urinary oxidative s tress markers. Science of the Total Environment, 2022, 807(Pt1): 0-150753.(IF: 7.963).

[29]. Ying Zhu*, Jianbo Tian* et al ...... Xiaoping Miao. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis. Eur J Cancer 2021;6:31006. (IF: 9.162, 中科院1 区).

[30]. 田剑波 ...... 李江、李霓、赫捷. 全球结直肠癌筛查指南及共识质量评价. 中华流行病学杂志 2021 (中文核心).

[31]. 田剑波, 缪小平, 林东昕. 中国人群常见恶性肿瘤遗传风险预测模型研究进展. 生物产业技术 2016;0 (中文核心).

[2]. Yimin Cai#, Zequn Lu#, Can Chen#, Ying Zhu#, ...... ，Jianbo Tian* & Xiaoping Miao. An atlas of genetic effects on cellular composition of the tumor microenvironment.* Nat Immunol 2024 (IF:27.7，中科院1区).

[3]. Cai Yimin#, Lu Zequn#, Li Bin# ...... Miao Xiaoping, Zhang Shaokai, Wei Yongchang, Tian Jianbo Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers. Mil Med Res 2024.11(1):36 (IF:16.7, 中科院1区).

[5]. Ying Pingting#, Chen Can#, Lu Zequn #, ...... ,Tian Jianbo, Miao Xiaoping. Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk.. Nature communications 2023,14(1):5958（IF:16.6, 中科院1区）.

[6]. Ming Zhang#, Xiaoyang Wang#, Nan Yang#, Xu Zhu#, ...... , Shaokai Zhang, Jianbo Tian, Xiaoping Miao. Prioritization of risk genes in colorectal cancer by integrative analysis of multi-omics data and gene networks.* Science China Life Science (IF:9.1, 中科院1区).

[7]. Bin Li#, Yimin Cai#, Can Chen#, ......, Jianbo Tian, Xiaoping Miao. Genetic variants that impact alternative polyadenylation in cancer represent candidate causal risk loci. Cancer Research (IF:13.21，中科院1区).

[8]. Ming Zhang#, Can Chen#, Zequn Lu#, ... , Jianbo Tian, Xiaoping Miao. Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms. Gastroenterology 2023, S0016-5085(23)04839-4 (IF:29.4, 中科院1区).

[9]. Meng Jin#, Bo Liu#, Can Chen#, ......., Jianbo Tian, Ke Hu Genome-wide splicing QTL analysis identifies causal risk variants for non-small cell lung cancer. Cancer Res. 2023 (IF: 13.31, 中科院1区).

[10]. Wang Haoxue#, Cai Yimin#, Jin Meng#, Huang ChaoQun#, et al ......Yang Xiaojun, Chang Jiang, Li Ni, Tian Jianbo Identification of specific susceptibility loci for the early-onset colorectal cancer. Genome Med. 2023,15(1):13 (IF:15.266, 中科院1区).

[11]. Chen Can#, Cai Yimin#, Liu Yizhuo#, et al ....... Miao Xiaoping, Yang Xiaojun, Zhu Ying, Tian Jianbo* Pan-cancer analysis of microbiome quantitative trait loci. Cancer Res. 2022, 82(19):3449-3456 (IF: 12.701, 中科院1区).

[12]. Tian Jianbo#, Chen Can#, Rao Meilin#, et al ...... Yang Xiaojun, Miao Xiaoping* Aberrant RNA splicing is a primary link between genetic variation and pancreatic cancer risk. Cancer Res. 2022, 82(11):2084-2096 (IF: 12.701,中科院1区).

[14]. Tian Jianbo#, Zhu Ying#, et al …… Chang Jiang, Miao Xiaoping. N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression. Gut, 2020, 69(12): 2180-2192.

[16]. Tian Jianbo#, Lou Jiao# et al…… Miao Xiaoping. Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both FADS2 and AP002754.2.* Cancer research, 2020, 80(9): 1804-1818. (IF: 12.701, 中科院1区).

[17]. Tian Jianbo#, Cai Yimin#, et al…… Miao Xiaoping. CancerImmunityQTL: a database to systematically evaluate the impact of genetic variants on immune infiltration in human cancer.* Nucleic acids research, 2021, 49(D1): D1065-D1073. (IF:16.971, 中科院1区).

[18]. Tian Jianbo#, Wang Zhihua#, et al…… Gong Jing, Han Leng, Miao Xiaoping. CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer.* Nucleic acids research, 2019, 47(D1): D909-D916. (IF:16.971, 中科院1区).

[20]. Gong Jing#, Tian Jianbo#, et al …… Miao Xiaoping. A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267.* Annals of oncology, 2018, 29(3): 632-639. (IF: 32.976, 中科院1区).

[23]. Tian Jianbo#, Ying Pingting#, et al…… Chang Jiang, Miao Xiaoping. ANKLE1 N6-Methyladenosine-related variant is associated with colorectal cancer risk by maintaining the genomic stability. International journal of cancer, 2020, 146(12): 3281-3293. (IF: 7.396, 中科院1区).

[25]. Wang Haoxue, et al…… Tian Jianbo, Miao Xiaoping. Colorectal cancer risk variant rs7017386 modulates two oncogenic lncRNAs expression via ATF1-mediated long-range chromatin loop. Cancer Lett, 2021, (IF: 8.671, 中科院1区).

[26]. Ying Pingting, et al…… Tian Jianbo, Chang Jiang. Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population. Arch Toxicol, 2021, 95(3): 1117-1128. (IF: 5.153, 中科院1区).

[27]. Jianbo Tian, Ming Zhang, Meng Jin* et al ...... Ke Hu, Xiaoping Miao, Huilan Zhang. Repurposed Tocilizumab in Patients with Severe COVID-19.* J Immunol 2021; 206(3):599-606. (IF: 5.424).

[29]. Ying Zhu, Jianbo Tian et al ...... Xiaoping Miao. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis. Eur J Cancer 2021;6:31006. (IF: 9.162, 中科院1 区).